Moderna adding 2,000 new workers this year
Moderna will add to its workforce and its U.S. real estate footprint, the biotech company announced in a press release Friday. The employees will be added by the end of the year.
Scientists have reversed the aging process in mice: Are humans next?
Johns Hopkins' Dr. Marty Makary says it may sound like "pie in the sky," but the aging process may be reversible after new findings from Harvard scientists.
New research suggests simple ways to help ease burnout
Although the research regarding simple ways to ease burnout was conducted on healthcare workers, the study's authors say the lessons can be applied to any profession.
Narcan maker gets fast-tracked for over-the-counter nasal spray
FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.
FDA takes tougher line on fast-tracked drugs
The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.
Researchers discover how to delay the decay of cells and tissue, restore function
Researchers have discovered a way to delay the decay of tissues and cells after death and even restore function to those cells. This is promising for organ transplant survivability.
UnitedHealth sees growing enrollment in 2Q thanks to Optum Health
UnitedHealth saw an 18% boost in revenue to about $45.1 billion in 2Q. A big reason for the strong quarter was Optum Health's performance. Optum's revenue per customer increased by 30%
Curevac sues BioNTech over COVID-19 vaccine's mRNA technology
CureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.
Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.
Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said.
Merck COVID-19 pill sparks calls for access for lower income countries
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
Bill & Melinda Gates Foundation gives Dare Bioscience a boost
Shares of Daré Bioscience, Inc., surged 63% ahead of Wednesday's opening bell after the biotech company reported a nearly $49 million grant from The Bill & Melinda Gates Foundation.
Coronavirus tests: which one should you take?
Trump orders new coronavirus tests, who will get them first?
When a coronavirus vaccine might be ready
Dr. Weiner says this is the fastest a vaccine has been advanced to the clinic in history
Prototype bionic leg could revolutionize prosthetics
Engineers at the Bionic Engineering Lab at the University of Utah are creating new tech that may make traditional prosthetics a thing of the past.
Can coffee cause cancer?
The link between coffee and cancer
Girl's HIV infection seems under control without AIDS drugs
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines.
Correction: Global Cyberattack story
Britain's National Cyber Security Center says teams are working "round the clock" to restore hospital computer systems after a global cyberattack that hit dozens of countries forced British hospitals to cancel and delay treatment for patients.
World cyberattack cripples UK hospitals, demands ransoms
Several British hospitals say they are having major computer problems as the result of an apparent cyberattack.